Inferior turbinate reduction (radiofrequency or microdebrider) is postponed until postpartum unless there is severe obstruction with OSA refractory to all medical therapy. General anesthesia and bleeding risks (hypervascular nasal mucosa) make surgery during pregnancy a last resort.
Nasal stuffiness during pregnancy is not a trivial complaint. It is a predictable, physiological consequence of rising estrogen, progesterone, and plasma volume. While self-limited, chronic congestion disrupts sleep, increases the risk of obstructive sleep apnea, and diminishes maternal quality of life. A stepped care model—beginning with humidification and saline irrigation, progressing to intranasal budesonide or fluticasone for persistent symptoms—offers safe and effective relief. Oral decongestants should be reserved for short-term, second-trimester use only when absolutely necessary. By addressing rhinitis of pregnancy proactively, clinicians can improve sleep, reduce hypertensive complications, and support a healthier transition to the postpartum period. stuffiness and pregnancy
Nasal obstruction is a known risk factor for OSA. Pregnancy-induced rhinitis, combined with weight gain and upper airway edema, can precipitate de novo OSA or worsen pre-existing disease. Maternal OSA has been linked to: It is a predictable, physiological consequence of rising